Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Operating Margin (2016 - 2026)

Iradimed has reported Operating Margin over the past 14 years, most recently at 32.93% for Q1 2026.

  • Quarterly Operating Margin rose 509.0% to 32.93% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 9.0% through Mar 2026, down 2114.0% year-over-year, with the annual reading at 7.11% for FY2025, 2288.0% down from the prior year.
  • Operating Margin was 32.93% for Q1 2026 at Iradimed, up from 57.72% in the prior quarter.
  • Over five years, Operating Margin peaked at 35.78% in Q3 2023 and troughed at 57.72% in Q4 2025.
  • The 5-year median for Operating Margin is 30.77% (2023), against an average of 25.15%.
  • Year-over-year, Operating Margin soared 1395bps in 2022 and then plummeted -8763bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 28.62% in 2022, then increased by 3bps to 29.57% in 2023, then grew by 1bps to 29.92% in 2024, then plummeted by -293bps to 57.72% in 2025, then skyrocketed by 157bps to 32.93% in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Operating Margin are 32.93% (Q1 2026), 57.72% (Q4 2025), and 32.23% (Q3 2025).